AUGUST 2025 NEWSLETTER
The newsletter of the Feinberg School of Medicine Research Office
 |
New Core to Visualize the Molecular Basis of Human Disease |
| A new core facility is opening this month to provide Northwestern investigators with access and training to use a Glacios-2 Cryo-Transmission Electron Microscope (X-FEG 200 kV, Falcon 4i detector and Selectris energy filter). The Feinberg Advanced Cryo Electron-Microscopy and Tomography (FACET) core is located in the sub-basement of the Simpson Querrey Biomedical Research Center. |
 |
Research Day Keynote: "Treating Cardiac Fibrosis with mRNA and CAR T-cells" |
|
Join us for the 19th Annual Lewis Landsberg Research Day on Thursday, September 11. Jonathan Epstein, MD, Dean of Perelman School of Medicine, will present the keynote address followed by poster presentations. |
Faculty ProfileImproving the Understanding and Treatment of Anxiety and Trauma-Related DisordersLuis Rosas-Vidal, MD, PhD, is an assistant professor of Psychiatry and Behavioral Sciences in the Division of General Psychiatry. A physician-scientist, his clinical interest focuses on the treatment of severe affective and psychotic disorders within the inpatient psychiatric unit. |
|
Student ProfileSeeking to Improve Quality of Life for Individuals with Limb LossEmily Dinelli is a PhD student in the Health Sciences Integrated PhD Program (HSIP) Program. Currently, she works within the Center for Rehabilitation Outcomes Research at Shirley Ryan AbilityLab, where she investigates systemic and clinical changes that could improve quality of life for individuals with limb loss. |
|
Post-Doc ProfileInvestigating the Neuroscience of AgingRogan Grant, PhD, is a Schmidt Science Fellow and Kimberly Querrey Fellow at Feinberg studying the intersection of mitochondrial dysfunction and neuroinflammation. After completing his PhD in neuroscience, Grant comitted to continuing his research in the laboratory of Navdeep Chandel, PhD. |
|
Campus Events |
||||||||
|
Research in the NewsNewsweek, August 7 New York Times, August 7 TODAY, July 31 |
NUCATS CornerAnnual Mentor Development Series Schedule ReleasedThe 2025-26 Mentor Development Series will take place in-person on the third Wednesday of the month from 9 to 10:30 a.m. starting October 15. Registration within the MyHR Learn system is required. Please view the 2025-26 workshop schedule. Interested faculty have the opportunity to complete the Mentor Training Certificate Program, which fulfills NIH requirements for faculty mentors on T32 and other training grants. Email Morgan Barrowman with any questions. |
|
Breakthroughs Podcast RewindExploring Immune Tolerance and Food Allergy Pathways with Stephanie Eisenbarth, MD, PhDIn this episode, Eisenbarth discusses the variety of immunology research taking place within the center and the continued work to discover and translate innovative science into cures for immune-related diseases. |
|
New FacultyTara O. Henderson, MD, MPH, FASCO, joined Feinberg in March as the Founder’s Board Chair of Pediatrics. She trained in pediatrics at the Johns Hopkins Hospital and in pediatric hematology-oncology at the Boston Children’s Hospital/Dana-Farber Cancer Institute combined program. Mostly recently, she was at the University of Chicago, where she founded and directed one of the premier childhood, adolescent and young adult cancer survivorship programs in the country. Her research has been funded by the National Institutes of Health (NIH) since 2008. She has made seminal observations regarding the risk and risk factors for subsequent malignancies in childhood cancer survivors, has developed internationally adopted breast and colorectal cancer surveillance guidelines for childhood, adolescent and young adult cancer survivors and more. |
|
Galter LibraryNIH Public Access Policy: New UpdatesOver the past two months the library has fielded a range of questions from authors, administrators, and research teams as we navigate these changes together. Review some of the most frequently asked questions Galter librarians have received and summarize key updates. |
|
High Impact ResearchMcGrosky A, Luke A, Arab L, Bedu-Addo K, Bonomi AG, Bovet P, Brage S, Buchowski MS, Butte N, Camps SG, Casper R, Cummings DK, Krupa Das S, Deb S, Dugas LR, Ekelund U, Forrester T, Fudge BW, Gillingham M, Goris AH, Gurven M, Hambly C, Joosen A, Katzmarzyk PT, Kempen KP, Kraus WE, Kriengsinyos W, Kuriyan R, Kushner RF, Lambert EV, Larsson CL, Leonard WR, Lessan N, Löf M, Martin CK, Medin AC, Neuhouser ML, Pietilainen KH, Plasqui G, Prentice RL, Racette SB, Raichlen DA, Ravussin E, Redman L, Reynolds RM, Rimm EB, Roberts S, Rosinger AY, Samuels MH, Sinha S, Snodgrass JJ, Stice E, Uauy R, Urlacher SS, Verbunt JA, Wolfe B, Wood B, Zhang X, Murphy-Alford AJ, Loechl CJ, Rood J, Sagayama H, Schoeller DA, Westerterp KR, Wong WW, Yamada Y, Speakman JR, Pontzer H. Energy expenditure and obesity across the economic spectrum. Proceedings of the National Academy of Sciences of the United States of America. Jul 2025; 122(29):e2420902122-e2420902122. Mohamed A, Richardson AI. Therapy-related juvenile myelomonocytic leukemia. Blood. Jul 2025; 146(1):127-127. Morales FL, Xu F, Lee HA, Tejedor Navarro H, Bechel MA, Cameron EL, Kelso J, Weiss CH, Nunes Amaral LA. Open-source computational pipeline flags instances of acute respiratory distress syndrome in mechanically ventilated adult patients. Nature Communications. Jul 2025; 16(1):6787-6787. Nguyen MP, Chen WC, Mirchia K, Choudhury A, Zakimi N, Nitturi V, Klisch TJ, Magill ST, Lucas CG, Patel AJ, Raleigh DR. Pan-cancer copy number analysis identifies optimized size thresholds and co-occurrence models for individualized risk stratification. Nature Communications. Jul 2025; 16(1):6024-6024. |
Featured CoreProteomics CoresThe mission of Northwestern Proteomics is to develop new proteomics technologies; to apply them to timely questions in basic, translational, and clinical research; to educate researchers throughout the Chicagoland area; and to communicate our research findings to the wider scientific community. Services
|
Funding Opportunities
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
HIV Prevention and Alcohol (R34 Clinical Trials Optional)
|
NIH NewsNIH to Crack Down on Excessive Publisher Fees for Publicly Funded Research As part of its ongoing commitment to scientific transparency and responsible stewardship of taxpayer dollars, the National Institutes of Health (NIH) today announced plans to implement a new policy that will cap how much publishers can charge NIH-supported scientists to make their research findings publicly accessible. This initiative reflects a broader effort to restore public trust in public health by promoting open, honest, and transparent scientific communication. This reform builds on NIH’s long-standing commitment to open science and public access, as demonstrated by initiatives such as:
|
Thank You For ReadingWe are testing an updated format for this newsletter. We welcome your feedback. Please share it with us via email. |
|
|
